Fig. 6From: Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from ChinaCA125 in patients with different BRCA status in exploratory therapy group. Note: There were seven patients with BRCA wild-type and three patients with BRCA status unknown in this groupBack to article page